Trefoil Factor 3 as an Endocrine Neuroprotective Factor from the Liver in Experimental Cerebral Ischemia/Reperfusion Injury

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Liu, Shu Q ^a   Roberts, Derek ^a   Zhang, Brian ^a   Ren, Yupeng ^b   Zhang, Li Qun ^b   Wu, Yu H ^a  

^a Northwestern University   (United States)

^b REHABILITATION INSTITUTE OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; MICROTUBULE ASSOCIATED PROTEIN 2; NEUROPROTECTIVE AGENT; PROSPEC; RECOMBINANT TREFOIL FACTOR 3; SECRETORY PROTEIN; TREFOIL FACTOR 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CELL DEATH; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FORELIMB; GRIP STRENGTH; HEMISPHERE; LEUKOCYTE; LIVER; LIVER CELL; MOTOR DYSFUNCTION; MOUSE; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REPERFUSION INJURY; TISSUE DISTRIBUTION; UPREGULATION;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CASPASE 3; CELL DEATH; CELL MOVEMENT; DISEASE MODELS, ANIMAL; HEPATECTOMY; HEPATOCYTES; LEUKOCYTES; LIVER; MICE; MICROTUBULE-ASSOCIATED PROTEINS; MUCINS; NEUROPROTECTIVE AGENTS; REPERFUSION INJURY; UP-REGULATION;

EID: 84885746397     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077732     Document Type: Article

References (81)

1. Liu XQ, Sheng R, Qin ZH, (2009) The neuroprotective mechanism of brain ischemic preconditioning. Acta Pharmacol Sin 30: 1071-1080. doi:10.1038/aps.2009.105. PubMed: 19617892.
2. Zhou AM, Li WB, Li QJ, Liu HQ, Feng RF, et al. (2004) A short cerebral ischemic preconditioning up-regulates adenosine receptors in the hippocampal CA1 region of rats. Neurosci Res 48: 397-404. doi:10.1016/j.neures.2003.12.010. PubMed: 15041193.
3. Dave KR, Lange-Asschenfeldt C, Raval AP, Prado R, Busto R, et al. (2005) Ischemic preconditioning ameliorates excitotoxicity by shifting glutamate/gamma-aminobutyric acid release and biosynthesis. J Neurosci Res 82: 665-673. doi:10.1002/jnr.20674. PubMed: 16247804.
4. Perez-Pinzon MA, (2007) Mechanisms of neuroprotection during ischemic preconditioning: Lessons from anoxic tolerance. Comp Biochem Physiol A Mol Integr Physiol 147: 291-299. doi:10.1016/j.cbpa.2006.08.032. PubMed: 17045830.
5. Sommer C, Fahrner A, Kiessling M, (2003) Postischemic neuroprotection in the ischemia-tolerant state gerbil hippocampus is associated with increased ligand binding to inhibitory GABA(A) receptors. Acta Neuropathol (Berl) 105: 197-202. PubMed: 12557004.
6. He X, Sandhu HK, Yang Y, Hua F, Belser N, et al. (2012) Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events. Cell Mol Life Sci [Epub ahead of print]. PubMed: 23014992.
7. Zhang Y, Wu YX, Hao YB, Dun Y, Yang SP, (2001) Role of endogenous opioid peptidesin protection of ischemic preconditioning in rat small intestine. Life Sci 68: 1013-1019. doi:10.1016/S0024-3205(00)01004-3. PubMed: 11212864.
8. Ohtsuki T, Ruetzler CA, Tasaki K, Hallenbeck JM, (1996) Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons. J Cerb Blood Flow Metab 16: 1137-1142. PubMed: 8898685.
9. Acalovschi D, Wiest T, Hartmann M, Farahmi M, Mansmann U, et al. (2003) Multiple levels of regulation of the interleukin-6 system in stroke. Stroke 34: 1864-1869. doi:10.1161/01.STR.0000079815.38626.44. PubMed: 12843357.
10. Obrenovitch TP, (2008) Molecular physiology of preconditioning-induced brain tolerance to ischemia. Physiol Rev 88: 211-247. doi:10.1152/physrev.00039.2006. PubMed: 18195087.
11. Smith CJ, Emsley HC, Gavin CM, Georgiou RF, Vail A, et al. (2004) Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol 4: 2. doi:10.1186/1471-2377-4-2. PubMed: 14725719.
12. Suzuki S, Tanaka K, Suzuki N, (2009) Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab 29: 464-479. doi:10.1038/jcbfm.2008.141. PubMed: 19018268.
13. Waje-Andreassen U, Kråkenes J, Ulvestad E, Thomassen L, Myhr KM, et al. (2005) IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol Scand 111: 360-365. doi:10.1111/j.1600-0404.2005.00416.x. PubMed: 15876336.
14. Noguchi CT, Asavaritikrai P, Teng R, Jia Y, (2007) Role of erythropoietin in the brain. Crit Rev Oncol/Hematol 64: 159-171. doi:10.1016/j.critrevonc.2007.03.001. PubMed: 17482474.
15. Prass K, Scharff A, Ruscher K, Löwl D, Muselmann C, et al. (2003) Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 34: 1981-1986. doi:10.1161/01.STR.0000080381.76409.B2. PubMed: 12829864.
16. Larsson E, Nanobashvili A, Kokaia Z, Lindvall O, (1999) Evidence for neuroprotective effects of endogenous brain-derived neurotrophic factor after global forebrain ischemia in rats. J Cereb Blood Flow Metab 19: 1220-1228. PubMed: 10566968.
17. Truettner J, Busto R, Zhao W, Ginsberg MD, Pérez-Pinzón MA, (2002) Effect of ischemic preconditioning on the expression of putative neuroprotective genes in the rat brain. Brain Res. Mol Brain Res 103: 106-115. doi:10.1016/S0169-328X(02)00191-2. PubMed: 12106696.
18. Ali C, Docagne F, Nicole O, Lesné S, Toutain J, et al. (2001) Increased expression of transforming growth factor-beta after cerebral ischemia in the baboon: An endogenous marker of neuronal stress? J Cereb Blood Flow Metab 21: 820-827. PubMed: 11435794.
19. Ata KA, Lennmyr F, Funa K, Olsson Y, Terént A, (1999) Expression of transforming growth factor-beta1, 2, 3 isoforms and type I and II receptors in acute focal cerebral ischemia: An immunohistochemical study in rat after transient and permanent occlusion of middle cerebral artery. Acta Neuropathol 97: 447-455. doi:10.1007/s004010051013. PubMed: 10334481.
20. Dobolyi A, Vincze C, Pál G, Lovas G, (2012) The neuroprotective functions of transforming growth factor Beta proteins. Int J Mol Sci 13: 8219-8258. doi:10.3390/ijms13078219. PubMed: 22942700.
21. Doyle KP, Cekanaviciute E, Mamer LE, Buckwalter MS, (2010) TGFbeta signaling in the brain increases with aging and signals to astrocytes and innate immune cells in the weeks after stroke. J Neuroinflammation 7: 62. doi:10.1186/1742-2094-7-62. PubMed: 20937129.
22. Krupinski J, Kumar P, Kumar S, Kaluza J, (1996) Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans. Stroke 27: 852-857. doi:10.1161/01.STR.27.5.852. PubMed: 8623105.
23. Vincze C, Pál G, Wappler EA, Szabó ER, Nagy ZG, et al. (2010) Distribution of mRNAs encoding transforming growth factors-beta1,-2, and-3 in the intact rat brain and after experimentally induced focal ischemia. J Comp Neurol 518: 3752-3770. doi:10.1002/cne.22422. PubMed: 20653032.
24. Zhu Y, Culmsee C, Roth-Eichhorn S, Krieglstein J, (2001) Beta(2)-adrenoceptor stimulation enhances latent transforming growth factor-beta-binding protein-1 and transforming growth factor-beta1 expression in rat hippocampus after transient forebrain ischemia. Neuroscience 107: 593-602. doi:10.1016/S0306-4522(01)00357-8. PubMed: 11720783.
25. Sun FY, Guo X, (2005) Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor. J Neurosci Res 79: 180-184. doi:10.1002/jnr.20321. PubMed: 15573409.
26. Bhuiyan MI, Kim YJ, (2010) Mechanisms and prospects of ischemic tolerance induced by cerebral preconditioning. Int Neurourol J 14: 203-212. doi:10.5213/inj.2010.14.4.203. PubMed: 21253330.
27. Dirnagl U, Simon RP, Hallenbeck JM, (2003) Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 26: 248-254. doi:10.1016/S0166-2236(03)00071-7. PubMed: 12744841.
28. Li B, Piao CS, Liu XY, Guo WP, Xue YQ, et al. (2010) Brain self-protection: the role of endogenous neural progenitor cells in adult brain after cerebral cortical ischemia. Brain Res 1327: 91-102. doi:10.1016/j.brainres.2010.02.030. PubMed: 20171958.
29. Liu SQ, Wu YH, (2009) Cardioprotective effects of hepatic cell-derived factors in myocardial ischemia. Current Topics Biochemical Res, 11: 65-77.
30. Liu SQ, Wu YH, (2010) Liver cell-mediated alleviation of acute ischemic myocardial injury. Frontiers in Bioscience (Elite Ed) 2: 711-724.
31. Liu SQ, Tefft BJ, Dong B, (2012) Liver-Mediated Myocardial Protection in Experimental Myocardial Infarction. J Clinic Exp Cardiol S7: 002.
32. Liu SQ, Ren YP, Zhang L-Q, Li YC, Phillips H, et al. (2012) Cardioprotective proteins upregulated in the liver in response to experimental myocardial ischemia. Am J Physiol Heart Circ Physiol 303: H1446-H1458. doi:10.1152/ajpheart.00362.2012. PubMed: 23064833.
33. Taupin D, Podolsky DK, (2003) Trefoil factors: Initiators of mucosal healing. Nat Rev Mol Cell Biol 4: 721--734. doi:10.1038/nrm1203. PubMed: 14506475.
34. Wong WM, Poulsom R, Wright NA, (1999) Trefoil peptides. Gut 44: 890-895. doi:10.1136/gut.44.6.890. PubMed: 10323896.
35. Gött P, Beck S, Machado JC, Carneiro F, Schmitt H, et al. (1996) Human trefoil peptides: genomic structure in 21q22.3 and coordinated expression. Eur J Hum Genet 4: 308-315. PubMed: 9043862.
36. Burmeister M, Meyer GE, (1997) The trefoil gene maps to mouse chromosome 17. Mamm Genome 8: 223-224. doi:10.1007/s003359900625. PubMed: 9072957.
37. Chinery R, Poulsom R, Cox HM, (1996) The gene encoding mouse intestinal trefoil factor: structural organization, partial sequence analysis and mapping to murine chromosome 17q. Gene 171: 249-253. doi:10.1016/0378-1119(96)00074-1. PubMed: 8666281.
38. Mouse Genome Informatics (MGI), http://www.informatics.jax.org/marker/MGI:104638.
39. Probst JC, Zetzsche T, Weber M, Theilemann P, Skutella T, et al. (1996) Human intestinal trefoil factor is expressed in human hypothalamus and pituitary: evidence for a novel neuropeptide. FASEB J 10: 1518-1523. PubMed: 8940297.
40. Hertel SC, Chwieralski CE, Hinz M, Rio MC, Tomasetto C, et al. (2004) Profiling trefoil factor family (TFF) expression in the mouse: identification of an antisense TFF1-related transcript in the kidney and liver. Peptides 25: 755-762. doi:10.1016/j.peptides.2003.11.021. PubMed: 15177869.
41. Babyatsky MW, deBeaumont M, Thim L, Podolsky DK, (1996) Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats. Gastroenterology 110: 489-497. doi:10.1053/gast.1996.v110.pm8566596. PubMed: 8566596.
42. Kinoshita K, Taupin DR, Itoh H, Podolsky DK, (2000) Distinct Pathways of Cell Migration and Antiapoptotic Response to Epithelial Injury: Structure-Function Analysis of Human Intestinal Trefoil Factor. Mol Cell Biol 20: 4680-4690. doi:10.1128/MCB.20.13.4680-4690.2000. PubMed: 10848594.
43. Kjellev S, Thim L, Pyke C, Poulsen SS, (2007) Cellular localization, binding sites, and pharmacologic effects of TFF3 in experimental colitis in mice. Dig Dis Sci 52: 1050-1059. doi:10.1007/s10620-006-9256-4. PubMed: 17342398.
44. Mahmood A, Melley L, Fitzgerald AJ, Ghosh S, Playford RJ, (2005) Trial of trefoil factor 3 enemas, in combination with oral 5-aminosalicylic acid, for the treatment of mild-to-moderate left-sided ulcerative colitis. Aliment Pharmacol Ther 21: 1357-1364. doi:10.1111/j.1365-2036.2005.02436.x. PubMed: 15932366.
45. Mashimo H, Wu DC, Podolsky DK, Fishman MC, (1996) Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 274: 262-265. doi:10.1126/science.274.5285.262. PubMed: 8824194.
46. Poulsen SS, Kissow H, Hare K, Hartmann B, Thim L, (2005) Luminal and parenteral TFF2 and TFF3 dimer and monomer in two models of experimental colitis in the rat. Regul Pept 126: 163-171. doi:10.1016/j.regpep.2004.09.007. PubMed: 15664663.
47. Taupin DR, Kinoshita K, Podolsky DK, (2000) Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc Natl Acad Sci USA 97: 799-804. doi:10.1073/pnas.97.2.799. PubMed: 10639160.
48. Teng X, Xu LF, Zhou P, Sun HW, Sun M, (2009) Effects of trefoil peptide 3 on expression of TNF-alpha, TLR4, and NF-kappaB in trinitrobenzene sulphonic acid induced colitis mice. Inflammation 32: 120-129. doi:10.1007/s10753-009-9110-x. PubMed: 19238529.
49. Vandenbroucke K, Hans W, Van Huysse J, Neirynck S, Demetter P, et al. (2004) Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice. Gastroenterology 127: 502-513. doi:10.1053/j.gastro.2004.05.020. PubMed: 15300583.
50. Chinery R, Cox HM, (1995) Immunoprecipitation and characterization of a binding protein specific for the peptide intestinal trefoil factor. Peptides 16: 749-755. doi:10.1016/0196-9781(95)00045-L. PubMed: 7479312.
51. Tan XD, Hsueh W, Chang H, Wei KR, Gonzalez-Crussi F, (1997) Characterization of a putative receptor for intestinal trefoil factor in rat small intestine: identification by in situ binding and ligand blotting. Biochem Biophys Res Commun 237: 673-677. doi:10.1006/bbrc.1997.7144. PubMed: 9299425.
52. Buchan AM, Xue D, Slivka A, (1992) A new model of temporary focal neocortical ischemia in the rat. Stroke 23: 273-279. doi:10.1161/01.STR.23.2.273. PubMed: 1561658.
53. Coyle P, (1982) Middle cerebral artery occlusion in the young rat. Stroke 13: 855-859. doi:10.1161/01.STR.13.6.855. PubMed: 7147305.
54. Osypiw JC, Allen RL, Billington D, (1994) Subpopulations of rat hepatocytes separated by Percoll density-gradient centrifugation show characteristics consistent with different acinar locations. Biochem J 304: 617-624. PubMed: 7998999.
55. Liu SQ, Alkema PK, Tieche C, Tefft BJ, Liu DZ, et al. (2005) Negative regulation of monocyte adhesion to arterial elastic laminae by signal-regulatory protein alpha and SH2 domain-containing protein tyrosine phosphatase-1. J Biol Chem 28039294 - 39301.
56. Liu SQ, Tefft BJ, Zhang A, Zhang L-Q, Wu YH, (2008) Formation of smooth muscle α actin filaments in CD34-positive bone marrow cells in elastic lamina-dominant matrix of arteries. Matrix Biol 27: 282-294. doi:10.1016/j.matbio.2008.01.001. PubMed: 18258420.
57. Martins PN, Theruvath TP, Neuhaus P, (2008) Rodent models of partial hepatectomies. Liver Int 28: 3-11. PubMed: 18028319.
58. Schindl MJ, Redhead DN, Fearon KC, Garden OJ, Wigmore SJ, (2005) The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 54: 289-296. doi:10.1136/gut.2004.046524. PubMed: 15647196.
59. Poirier JL, Capek R, De Koninck Y, (2000) Differential progression of Dark Neuron and Fluoro-Jade labelling in the rat hippocampus following pilocarpine-induced status epilepticus. Neuroscience 97: 59-68. doi:10.1016/S0306-4522(00)00026-9. PubMed: 10771339.
60. Schmued LC, Hopkins KJ, (2000) Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874: 123-130. doi:10.1016/S0006-8993(00)02513-0. PubMed: 10960596.
61. Goldman J, Zhong L, Liu SQ, (2003) Degradation of α-actin filaments in venous smooth muscle cells in response to mechanical stretch. Am J Physiol Heart Circ Physiol 284: 1839-1847.
62. Lee JC, Ahn JH, Lee DH, Yan BC, Park JH, et al. (2013) Neuronal damage and gliosis in the somatosensory cortex induced by various durations of transient cerebral ischemia in gerbils. Brain Res 1510: 78-88. doi:10.1016/j.brainres.2013.03.008. PubMed: 23528266.
63. Abe T, Kunz A, Shimamura M, Zhou P, Anrather J, et al. (2009) The neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic. J Cereb Blood Flow Metab 29: 66-72. doi:10.1038/jcbfm.2008.88. PubMed: 18648380.
64. Li X, Blizzard KK, Zeng Z, DeVries AC, Hurn PD, et al. (2004) Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender. Exp Neurol 187: 94-104. doi:10.1016/j.expneurol.2004.01.004. PubMed: 15081592.
65. Kubli DA, Gustafsson AB, (2012) Mitochondria and mitophagy: the yin and yang of cell death control. Circ Res;111: 1208-1221. doi:10.1161/CIRCRESAHA.112.265819. PubMed: 23065344.
66. Gustafsson AB, Gottlieb RA, (2007) Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol;292: C45-C51. PubMed: 16943242.
67. Forbes S, Vig P, Poulsom R, Thomas H, Alison M, (2002) Hepatic stem cells. J Pathol 197: 510-518. doi:10.1002/path.1163. PubMed: 12115866.
68. Riehle KJ, Dan YY, Campbell JS, Fausto N, (2011) New concepts in liver regeneration. J Gastroenterol Hepatol 26 (Suppl 1) ():: 203-212. doi:10.1111/j.1440-1746.2010.06539.x. PubMed: 21199532.
69. Taub R, (2004) Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 5: 836-847. doi:10.1038/nrm1489. PubMed: 15459664.
70. Alison M, Golding M, Lalani El N, Sarraf C, (1998) Wound healing in the liver with particular reference to stem cells. Philos Trans R Soc Lond B Biol Sci 353: 877-894. doi:10.1098/rstb.1998.0252. PubMed: 9684285.
71. Böhm F, Köhler UA, Speicher T, Werner S, (2010) Regulation of liver regeneration by growth factors and cytokines. EMBO. Mol Med 2: 294-305.
72. Fausto N, Campbell JS, (2003) The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 120: 117-130. doi:10.1016/S0925-4773(02)00338-6. PubMed: 12490302.
73. Michalopoulos GK, DeFrances MC, (1997) Liver regeneration. Science 276: 60-66. doi:10.1126/science.276.5309.60. PubMed: 9082986.
74. Jander S, Schroeter M, Peters O, Witte OW, Stoll G, (2001) Cortical spreading depression induces proinflammatory cytokine gene expression in the rat brain. J Cereb Blood Flow Metab 21: 218-225. PubMed: 11295876.
75. Liu J, Ginis I, Spatz M, Hallenbeck JM, (2000) Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-alpha and ceramide. Am J Physiol Cell Physiol 278: C144-C153. PubMed: 10644522.
76. Saito K, Suyama K, Nishida K, Sei Y, Basile AS, (1996) Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain. Neurosci Lett 206: 149-152. doi:10.1016/S0304-3940(96)12460-5. PubMed: 8710173.
77. Schroeter M, Küry P, Jander S, (2003) Inflammatory gene expression in focal cortical brain ischemia: differences between rats and mice. Brain Res. Mol Brain Res 117: 1-7. doi:10.1016/S0169-328X(03)00255-9. PubMed: 14499475.
78. Huang J, Upadhyay UM, Tamargo RJ, (2006) Inflammation in stroke and focal cerebral ischemia. Surg Neurol; 66: 232-245. doi:10.1016/j.surneu.2005.12.028. PubMed: 16935624.
79. Karikó K, Weissman D, Welsh FA, (2004) Inhibition of toll-like receptor and cytokine signaling--a unifying theme in ischemic tolerance. J Cereb Blood Flow Metab 24: 1288-1304. PubMed: 15545925.
80. Liu D, el-Hariry I, Karayiannakis AJ, Wilding J, Chinery R, et al. (1997) Phosphorylation of beta-catenin and epidermal growth factor receptor by intestinal trefoil factor. Lab Invest 77: 557-563. PubMed: 9426392.
81. Taupin DR, Podolsky DK, (1999) Mitogen-activated protein kinase activation regulates intestinal epithelial differentiation. Gastroenterology 116: 1072-1080. doi:10.1016/S0016-5085(99)70010-7. PubMed: 10220499.